
Abridge Secures $250M Series D Funding and Launches AI Engine
Abridge has raised $250 million in Series D funding, announced in a press release. The investment round was co-led by Elad Gil and IVP, with participation from notable investors such as Bessemer Venture Partners, CapitalG, and NVIDIA's NVentures. This funding will support the development of Abridge's AI capabilities and commercial growth.
In addition to the funding announcement, Abridge has introduced a new Contextual Reasoning Engine. This AI architecture is designed to produce clinically useful and billable notes at the point of care, addressing the issue of incomplete clinical notes that delay billing processes. The engine integrates data from past patient encounters and health system-specific guidelines to create comprehensive notes, simplifying revenue cycle workflows.
Abridge's platform is now deployed in over 100 health systems, including major institutions like Duke Health, Johns Hopkins, and Mayo Clinic. The company aims to reduce administrative burdens and improve patient care by enabling clinicians to focus more on their patients rather than documentation.
We hope you enjoyed this article.
Consider subscribing to one of several newsletters we publish like Life AI Weekly.
Also, consider following us on social media:
More from: Healthcare & Life Sciences
Avio Health Unveils Functional Medicine LLM for Personalized Healthcare
Novo Nordisk Foundation Allocates DKK 479 Million for AI and Health Projects
Infinitus Expands AI Partnership with Salesforce for Healthcare
RevelAi Health Secures $3.1 Million to Enhance AI in Musculoskeletal Care
More from: Funding
Clio to Acquire vLex for $1 Billion, Expanding AI Legal Technology
Recognize Closes $1.7 Billion Fund for Digital Services Investments
Chang Robotics Fund Deploys Initial Capital to Boost U.S. Manufacturing
Audos Secures $11.5 Million to Empower AI Entrepreneurs
Gensmo Secures $60M to Revolutionize Fashion E-Commerce with AI
Subscribe to Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation
The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.
Read more